| Literature DB >> 28695171 |
Afitap Özdelikara1, Mehtap Tan2.
Abstract
OBJECTIVE: Patients receiving chemotherapy struggle with the side effects of this treatment. These side effects obligate the patients to use not only the pharmacological methods but also non-pharmacological relaxing methods. This study was conducted to determine the effect of reflexology on chemotherapy-induced nausea, vomiting, and fatigue in breast cancer patients.Entities:
Keywords: Breast cancer; nausea; nursing; reflexology
Year: 2017 PMID: 28695171 PMCID: PMC5473096 DOI: 10.4103/apjon.apjon_15_17
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Comparison of groups in terms of Rhodes index of nausea, vomiting, and retching mean scores of patients after reflexology
| INVR | Group | Onset | First measurement | Second measurement | Third measurement |
|---|---|---|---|---|---|
| Subscale of experience | |||||
| Nausea experience | Experimental | 8.63±3.16 | 2.53±2.80 | 2.56±2.94 | 2.06±3.33 |
| Control | 4.96±4.55 | 5.46±4.15 | 6.16±4.01 | 6.56±4.09 | |
| | 3.62 | −3.20 | −3.95 | −4.67 | |
| df | 58 | 58 | 58 | 58 | |
| | 0.001 | <0.001 | 0.000 | 0.000 | |
| Vomiting experience | Experimental | 4.03±4.08 | 0.83±1.57 | 0.86±1.97 | 0.96±2.39 |
| Control | 3.26±4.16 | 3.83±4.29 | 4.50±3.63 | 4.00±3.29 | |
| | 0.72 | −3.59 | −4.80 | −4.08 | |
| df | 58 | 58 | 58 | 58 | |
| | >0.05 | 0.001 | 0.000 | 0.000 | |
| Retching experience | Experimental | 5.33±2.45 | 1.23±1.27 | 0.96±1.77 | 0.86±1.92 |
| Control | 2.80±3.04 | 3.60±2.76 | 3.96±2.72 | 4.00±3.29 | |
| | 3.54 | −4.26 | −5.05 | −4.50 | |
| df | 58 | 58 | 58 | 58 | |
| | 0.001 | 0.000 | 0.000 | 0.000 | |
| Experience score | Experimental | 18.00±7.51 | 4.60±4.76 | 4.40±5.52 | 3.90±6.89 |
| Control | 11.03±11.24 | 12.90±10.49 | 14.63±9.62 | 6.56±4.09 | |
| | 2.82 | −3.94 | −5.05 | −1.82 | |
| df | 58 | 58 | 58 | 58 | |
| | <0.05 | 0.000 | 0.000 | >0.05 | |
| Subscale of symptom development | |||||
| Nausea development | Experimental | 5.86±2.14 | 1.83±2.05 | 1.80±2.02 | 1.43±2.35 |
| Control | 3.33±3.02 | 3.70±2.79 | 4.20±2.74 | 4.40±2.82 | |
| | 3.74 | −2.94 | −3.85 | −4.41 | |
| df | 58 | 58 | 58 | 58 | |
| | 0.000 | <0.05 | 0.000 | 0.000 | |
| Vomiting development | Experimental | 2.66±2.66 | 0.56±1.07 | 0.56±1.25 | 0.63±1.56 |
| Control | 2.03±2.72 | 2.40±2.82 | 2.80±2.36 | 2.40±2.02 | |
| | 0.910 | −3.32 | −4.56 | −3.77 | |
| df | 58 | 58 | 58 | 58 | |
| | >0.05 | <0.05 | 0.000 | 0.000 | |
| Retching development | Experimental | 2.56±1.43 | 0.60±0.67 | 0.56±1.10 | 0.43±1.00 |
| Control | 1.40±1.54 | 1.73±1.38 | 2.06±1.41 | 2.20±1.37 | |
| | 3.03 | −4.02 | −4.58 | −5.68 | |
| df | 58 | 58 | 58 | 58 | |
| | <0.05 | 0.000 | 0.000 | 0.000 | |
| Symptom development score | Experimental | 11.10±4.74 | 3.00±3.22 | 2.93±3.60 | 2.50±4.34 |
| Control | 6.76±6.85 | 7.83±6.41 | 9.06±5.91 | 9.00±5.29 | |
| | 2.84 | −3.68 | −4.84 | −5.19 | |
| df | 58 | 58 | 58 | 58 | |
| | <0.05 | 0.000 | 0.000 | 0.000 | |
| Subscale of distress development | |||||
| Nausea distress | Experimental | 2.76±1.19 | 0.70±0.83 | 0.76±1.00 | 0.63±0.99 |
| Control | 1.63±1.54 | 1.76±1.38 | 1.96±1.37 | 2.16±1.34 | |
| | 3.18 | −3.61 | −3.85 | −5.02 | |
| df | 58 | 58 | 58 | 58 | |
| | <0.05 | 0.001 | 0.000 | 0.000 | |
| Vomiting distress | Experimental | 1.36±1.47 | 0.26±0.52 | 0.30±0.79 | 0.33±0.84 |
| Control | 1.23±1.59 | 1.43±1.56 | 1.70±1.36 | 1.60±1.35 | |
| | 0.33 | −3.86 | −4.84 | −4.34 | |
| df | 58 | 58 | 58 | 58 | |
| | >0.05 | 0.000 | 0.000 | 0.000 | |
| Retching distress | Experimental | 2.76±1.19 | 0.26±0.52 | 0.40±0.72 | 0.43±0.97 |
| Control | 1.40±1.54 | 1.86±1.43 | 1.90±1.37 | 1.96±1.21 | |
| | 3.83 | −5.75 | −5.29 | −5.39 | |
| df | 58 | 58 | 58 | 58 | |
| | 0.000 | 0.000 | 0.000 | 0.000 | |
| Distress score | Experimental | 6.90±2.90 | 1.60±1.65 | 1.46±2.06 | 1.40±2.59 |
| Control | 4.2±4.47 | 5.06±4.13 | 5.56±3.82 | 5.73±3.55 | |
| | 2.70 | −4.26 | −5.16 | −5.39 | |
| df | 58 | 58 | 58 | 58 | |
| | <0.05 | 0.000 | 0.000 | 0.000 |
INVR: Rhodes index of nausea, vomiting, and retching
Figure 1Total scores of patients in the subscale of experience
Figure 2Total scores of patients in the subscale of symptom development
Figure 3Total scores of patients in the subscale of distress
Comparison of the groups in terms of Brief Fatigue Inventory mean scores
| BFI | Group | Onset | First measurement | Second measurement | Third measurement |
|---|---|---|---|---|---|
| Fatigue severity | Experimental | 3.67±1.94 | 1.62±1.41 | 1.28±1.61 | 1.20±1.44 |
| Control | 1.97±1.59 | 2.63±2.09 | 2.11±1.48 | 2.33±1.65 | |
| | 3.70 | −2.19 | −2.05 | −2.83 | |
| df | 58 | 58 | 58 | 58 | |
| | 0.000 | <0.05 | <0.05 | <0.05 | |
| Daily life activity exposure levels | Experimental | 1.88±1.26 | 0.53±1.17 | 0.51±0.98 | 0.41±0.65 |
| Control | 1.01±1.16 | 1.66±2.00 | 1.17±0.97 | 1.47±1.52 | |
| | 2.78 | −2.65 | −2.60 | −3.53 | |
| df | 58 | 58 | 58 | 58 | |
| | <0.05 | <0.05 | <0.05 | 0.001 |
BFI: Brief Fatigue Inventory
Figure 4Fatigue severity scores of patients after reflexology
Figure 5Daily life activity exposure level scores of patients regarding daily life activities after reflexology